At-Home Treatment for Heart Failure Edema Shows Promise in New Trial
A recent trial, SUBCUT HF II, has demonstrated that at-home treatment of heart failure-related edema using subcutaneous furosemide is both effective and safe, offering a viable alternative to traditional inpatient care. Conducted across 20 NHS hospitals in the U.K., the trial involved 172 patients and showed that those treated at home spent an average of four fewer days in the hospital compared to those receiving standard intravenous treatment. The trial's primary endpoint was the avoidance of a minimum of 3.5 days of inpatient care, which was successfully met. The study also reported low readmission rates and minimal adverse events, supporting the safety of this at-home treatment approach. 
